And this is. We've had an ongoing discussion about this, this coverage topic for last couple years, I believe, and maybe longer than that. And, you know, at the end of The decision [not to cover obesity drugs] comes down to the statutory limitation that the Board has in terms of adding new covered benefits that add a cost without having an offsetting cost savings. And to date, we haven't had sufficient data information provided to the Board that would essentially show us that there is cost savings that would be offset from the fairly significant additional cost from. (40:33)
CLAIM
Asserts that statutory limitations prevent the Board from adding new benefits without offsetting cost savings.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
